Targretin
$2,828.00
Bexarotene is an antineoplastic agent for use as a treatment for cutaneous T cell lymphoma. It is a third-generation retinoid
Brand Manufacturer: Sanofi
Indication: Bexarotene is indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in people who are refractory to at least one prior systemic therapy (oral) and for the topical treatment of cutaneous lesions in patients with CTCL who have refractory or persistent disease after other therapies or who have not tolerated other therapies (topical).